HIF1A and acute myeloid leukemia: In primary patient AML CD34+ cells, we observed that both HIF1 and HIF2 associated with glycolysis-related loci, although patient-specific differences were also noted, whereby HIF1 binding was more dominant than HIF2 in some cases (Fig. 2c, d).